Operating Lease, Right-of-Use Asset of Maze Therapeutics, Inc. from 31 Dec 2024 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of lessee's right to use underlying asset under operating lease.
- Summary
-
Maze Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
- Maze Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $20,116,000, a 13% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)
Maze Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $20,116,000 | -$3,134,000 | -13% | 31 Dec 2025 | 10-K | 25 Mar 2026 | 2025 | FY |
| Q3 2025 | $20,920,000 | 30 Sep 2025 | 10-Q | 06 Nov 2025 | 2025 | Q3 | ||
| Q2 2025 | $21,707,000 | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q2 | ||
| Q1 2025 | $22,483,000 | 31 Mar 2025 | 10-Q | 14 May 2025 | 2025 | Q1 | ||
| Q4 2024 | $23,250,000 | 31 Dec 2024 | 10-K | 25 Mar 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.